Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucose Monitoring, Topics Jul 11 | 2018Thoughts on New Dexcom G6 T2DM Basal-Only Study (MOBILE)Purchase Blast
$599
Posted in: SGLT2i, Topics Jul 10 | 2018BI/Lilly Sign Jardiance Outcomes-Based Contract with HighmarkPurchase Blast
$599
Posted in: Insulin Delivery, Topics Jul 10 | 2018Medtronic/UHC Value-Based Contract ResultsPurchase Blast
$599
Posted in: Glucose Monitoring, Other, Topics Jul 10 | 2018Senseonics to integrate with GlookoPurchase Blast
$599
Posted in: GLP-1RA, Topics Jul 03 | 2018Former Lilly Exec Thane Wettig Joins Intarcia As New Head of MarketingPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, Topics Jul 02 | 2018Thoughts on New Sanofi/Verily Connected Care Pre-filled T2DM Pump PartnershipPurchase Blast
$599
Posted in: SGLT2i, Topics Jul 02 | 2018EMPA-REG hHF and Renal Data Added to EU Jardiance LabelPurchase Blast
$599
Posted in: DPP-IVi, GLP-1RA, Topics Jun 28 | 2018Oral Semaglutide Superior to Januvia at 78 Weeks (PIONEER 3)Purchase Blast
$599
Posted in: Bolus Insulin, Insulin Delivery, Topics Jun 27 | 2018MannKind Re-Initiates TV DTC; Hosts Analyst MeetingPurchase Blast
$599
Posted in: SGLT2i, Topics Jun 25 | 2018BI/LLY Ph3 EASE Update – Jardiance in T1DMPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other, Topics Jun 25 | 2018“Smart CGM is a new category” - Medtronic ADA 2018 investor event summaryPurchase Blast
$599
Posted in: GLP-1RA, SGLT2i, Topics Jun 24 | 2018ADA ’18 Key Data Press Releases (June 24)Purchase Blast$599
Posted in: SGLT2i, Topics Jun 24 | 2018Imbalance in DKA Observed in DEPICT-2; Full 52-week inTandem1 dataPurchase Blast
$599
Posted in: Basal Insulin, Dual/triple agonist, GLP-1RA, Insulin Delivery, Topics Jun 24 | 2018New Novo CVOT strategy; ADA '18 Analyst BriefingPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon, SGLT2i, Topics Jun 23 | 2018Drug ADA ‘18 Key Data Press Releases (June 23)Purchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other, Topics Jun 23 | 2018Devices/Apps ADA ’18 Key Data Press Releases (June 23)Purchase Blast$599
Posted in: GLP-1RA, Topics Jun 21 | 2018More Thoughts on PIONEER-4 and Potential Novo Regulatory Strategy for Oral SemaglutidePurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 21 | 2018Senseonics Eversense CGM approved in the US; sPMA for insulin-dosing claim to followPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 21 | 2018Tandem’s t:slim X2 pump approved with Basal-IQ; Medtronic 670G approved for ages 7-13Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other, Topics Jun 20 | 2018Voluntis and Monarch Medical Partnership Will Compete with GlytecPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
